Oak Associates’s Johnson & Johnson JNJ Stock Holding History

Oak Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.51M	Hold	10,281	–	–	0.17%	72
2025 Q4	$2.13M	Sell	10,281 -202	-2%	-$39.9K	0.13%	73
2025 Q3	$1.94M	Hold	10,483	–	–	0.12%	75
2025 Q2	$1.6M	Hold	10,483	–	–	0.1%	83
2025 Q1	$1.74M	Buy	10,483 +300	+3%	+$46.9K	0.13%	80
2024 Q4	$1.47M	Hold	10,183	–	–	0.1%	92
2024 Q3	$1.65M	Hold	10,183	–	–	0.11%	84
2024 Q2	$1.49M	Hold	10,183	–	–	0.1%	88
2024 Q1	$1.61M	Hold	10,183	–	–	0.11%	89
2023 Q4	$1.6M	Buy	10,183 +1,444	+17%	+$221K	0.12%	90
2023 Q3	$1.36M	Buy	8,739 +200	+2%	+$33K	0.11%	90
2023 Q2	$1.41M	Sell	8,539 -800	-9%	-$129K	0.11%	94
2023 Q1	$1.45M	Sell	9,339 -3,669	-28%	-$592K	0.12%	94
2022 Q4	$2.3M	Hold	13,008	–	–	0.19%	82
2022 Q3	$2.13M	Buy	13,008 +3,865	+42%	+$654K	0.18%	71
2022 Q2	$1.62M	Sell	9,143 -5	-0.1%	-$891	0.13%	84
2022 Q1	$1.62M	Hold	9,148	–	–	0.1%	90
2021 Q4	$1.56M	Hold	9,148	–	–	0.08%	93
2021 Q3	$1.48M	Hold	9,148	–	–	0.08%	90
2021 Q2	$1.51M	Hold	9,148	–	–	0.09%	90
2021 Q1	$1.5M	Buy	9,148 +5	+0.1%	+$809	0.09%	90
2020 Q4	$1.44M	Hold	9,143	–	–	0.09%	94
2020 Q3	$1.36M	Hold	9,143	–	–	0.09%	91
2020 Q2	$1.29M	Hold	9,143	–	–	0.09%	88
2020 Q1	$1.2M	Hold	9,143	–	–	0.1%	79
2019 Q4	$1.33M	Sell	9,143 -2,992	-25%	-$406K	0.08%	96
2019 Q3	$1.57M	Sell	12,135 -2,315	-16%	-$305K	0.1%	87
2019 Q2	$2.01M	Hold	14,450	–	–	0.13%	83
2019 Q1	$2.02M	Sell	14,450 -8,040	-36%	-$1.08M	0.12%	83
2018 Q4	$2.9M	Buy	22,490 +1,000	+5%	+$139K	0.2%	73
2018 Q3	$2.97M	Hold	21,490	–	–	0.18%	80
2018 Q2	$2.61M	Hold	21,490	–	–	0.17%	81
2018 Q1	$2.75M	Sell	21,490 -210	-1%	-$28.4K	0.19%	77
2017 Q4	$3.03M	Hold	21,700	–	–	0.22%	74
2017 Q3	$2.82M	Hold	21,700	–	–	0.21%	85
2017 Q2	$2.87M	Hold	21,700	–	–	0.22%	87
2017 Q1	$2.7M	Hold	21,700	–	–	0.22%	89
2016 Q4	$2.5M	Hold	21,700	–	–	0.25%	88
2016 Q3	$2.52M	Hold	21,700	–	–	0.26%	85
2016 Q2	$2.63M	Hold	21,700	–	–	0.32%	76
2016 Q1	$2.35M	Hold	21,700	–	–	0.29%	79
2015 Q4	$2.23M	Hold	21,700	–	–	0.27%	81
2015 Q3	$2.03M	Hold	21,700	–	–	0.27%	82
2015 Q2	$2.12M	Hold	21,700	–	–	0.26%	85
2015 Q1	$2.18M	Hold	21,700	–	–	0.26%	86
2014 Q4	$2.27M	Hold	21,700	–	–	0.27%	82
2014 Q3	$2.31M	Hold	21,700	–	–	0.29%	74
2014 Q2	$2.27M	Hold	21,700	–	–	0.28%	77
2014 Q1	$2.13M	Buy	21,700 +1,000	+5%	+$92.7K	0.26%	78
2013 Q4	$1.9M	Buy	+20,700	New	+$1.91M	0.21%	86
2013 Q2	$1.78M	Buy	+20,700	New	+$1.76M	0.21%	81

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Oak Associates's JNJ Position: Q1 2026 in Review

Oak Associates held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 10,281 shares worth $2.51M. The position accounts for 0.17% of the portfolio, ranked #72.

Oak Associates first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.03M in Q4 2017. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Oak Associates held 10,281 shares of Johnson & Johnson worth $2.51M as of Q1 2026.
Oak Associates left its Johnson & Johnson share count unchanged in Q1 2026.
Johnson & Johnson made up 0.17% of Oak Associates's portfolio in Q1 2026, its #72 holding.
Oak Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
Oak Associates's Johnson & Johnson position peaked at $3.03M in Q4 2017.
4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Oak Associates's 13F filing for Q1 2026, filed 14 May 2026.